LEADER 02407nam0 22005053i 450 001 VAN00248979 005 20240806101416.689 017 70$2N$a9783030401054 100 $a20220804d2020 |0itac50 ba 101 $aeng 102 $aCH 105 $a|||| ||||| 200 1 $aDesign and Analysis of Subgroups with Biopharmaceutical Applications$fNaitee Ting ... [et al.] editors 210 $aCham$cSpringer$d2020 215 $axviii, 400 p.$cill.$d24 cm 410 1$1001VAN00248831$12001 $aEmerging Topics in Statistics and Biostatistics$1210 $aCham$cSpringer 500 1$3VAN00248981$aDesign and Analysis of Subgroups with Biopharmaceutical Applications$92547801 606 $a00B25$xProceedings of conferences of miscellaneous specific interest [MSC 2020]$3VANC020732$2MF 606 $a62-XX$xStatistics [MSC 2020]$3VANC022998$2MF 606 $a62F15$xBayesian inference [MSC 2020]$3VANC024528$2MF 606 $a62K05$xOptimal statistical designs [MSC 2020]$3VANC033803$2MF 606 $a62P10$xApplications of statistics to biology and medical sciences; meta analysis [MSC 2020]$3VANC024649$2MF 606 $a92-XX$xBiology and other natural sciences [MSC 2020]$3VANC020839$2MF 606 $a92B15$xGeneral Biostatistics [MSC 2020]$3VANC026442$2MF 610 $aBayesian Statistics$9KW:K 610 $aBenefit-risk$9KW:K 610 $aConfirmatory subgroup analysis$9KW:K 610 $aMeta-analysis$9KW:K 610 $aNetwork Meta-analysis$9KW:K 610 $aPersonalized medicine$9KW:K 610 $aPharmaceutical$9KW:K 610 $aPrecision medicine$9KW:K 610 $aSubgroup analysis$9KW:K 610 $aSubgroup identification$9KW:K 620 $aCH$dCham$3VANL001889 702 1$aTing$bNaitee$3VANV095311 712 $aSpringer $3VANV108073$4650 801 $aIT$bSOL$c20241115$gRICA 856 4 $uhttp://doi.org/10.1007/978-3-030-40105-4$zE-book ? Accesso al full-text attraverso riconoscimento IP di Ateneo, proxy e/o Shibboleth 899 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$1IT-CE0120$2VAN08 912 $fN 912 $aVAN00248979 950 $aBIBLIOTECA DEL DIPARTIMENTO DI MATEMATICA E FISICA$d08DLOAD e-book 4616 $e08eMF4616 20220804 996 $aDesign and Analysis of Subgroups with Biopharmaceutical Applications$92547801 997 $aUNICAMPANIA